Safety Study of an Immunomodulating Microparticle to Treat Progressive Multiple Sclerosis

Clinical trial NCT01191996 · COMPLETED

Trial details

NCT number: NCT01191996
Sponsor: Innate Immunotherapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Secondary Progressive Multiple Sclerosis Primary Progressive Multiple Sclerosis

Start date: 2010-08-01
Primary completion: 2012-06-01
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.